These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2827370)
1. Carcinoembryonic antigen and lectin binding in the bile canalicular structures of hepatocellular carcinoma. Machinami R; Oono Y Virchows Arch A Pathol Anat Histopathol; 1987; 412(2):111-8. PubMed ID: 2827370 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues. Kitagawa Y; Iwai M; Muramatsu A; Tanaka S; Mori T; Harada Y; Okanoue T; Kashima K Histopathology; 2002 May; 40(5):472-9. PubMed ID: 12010368 [TBL] [Abstract][Full Text] [Related]
3. Lectin binding patterns in normal liver, chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma. An immunohistochemical and immunoelectron microscopic study. Murakami I; Sarker AB; Hayashi K; Akagi T Acta Pathol Jpn; 1992 Aug; 42(8):566-72. PubMed ID: 1333146 [TBL] [Abstract][Full Text] [Related]
4. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma. Röcken C; Licht J; Roessner A; Carl-McGrath S J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153 [TBL] [Abstract][Full Text] [Related]
5. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections. Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399 [TBL] [Abstract][Full Text] [Related]
6. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma. Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946 [TBL] [Abstract][Full Text] [Related]
7. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma. Lagana SM; Salomao M; Remotti HE; Knisely AS; Moreira RK Histopathology; 2015 Mar; 66(4):598-602. PubMed ID: 25378077 [TBL] [Abstract][Full Text] [Related]
8. [Assay of the carcinoembryonic antigen (CEA) in acute and chronic liver diseases and hepatocellular carcinoma]. Piantino P; Gallo V; Pecchio F; Garlanda PF; Bonardi O Minerva Med; 1981 Apr; 72(17):1059-64. PubMed ID: 6262678 [TBL] [Abstract][Full Text] [Related]
9. Bile duct-specific lectins, Dolichos biflorus agglutinin and peanut agglutinin, as probes in mouse hepatocarcinogenesis. Takahashi K; Viviano CJ; Elwell MR; Bakewell WE; Kuwahara M; Nakashima N; Blackwell BN; Maronpot RR Lab Invest; 1995 Sep; 73(3):424-32. PubMed ID: 7564276 [TBL] [Abstract][Full Text] [Related]
10. [Value of the determination of carcinoembryonic antigen (CEA) in benign and tumoral digestive pathology, chronic hepathopathies and hepatomas: study of 190 cases]. Escudero Navarro JM; Rodrigo Saez L; Morcillo Herrera L; Faedo Presa I; Cornago Sánchez A; Pérez Alvarez R; García Saavedra L Rev Esp Enferm Apar Dig; 1980 Sep; 58(3):267-74. PubMed ID: 6256829 [No Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material. Wong MA; Yazdi HM Acta Cytol; 1990; 34(2):192-6. PubMed ID: 2157322 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas. Stroescu C; Herlea V; Dragnea A; Popescu I J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226 [TBL] [Abstract][Full Text] [Related]
15. Profiles of expression of carbohydrate chain structures during human intrahepatic bile duct development and maturation: a lectin-histochemical and immunohistochemical study. Terada T; Nakanuma Y Hepatology; 1994 Aug; 20(2):388-97. PubMed ID: 8045500 [TBL] [Abstract][Full Text] [Related]
16. Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma. Stecca BA; Nardo B; Chieco P; Mazziotti A; Bolondi L; Cavallari A J Hepatol; 1997 Aug; 27(2):337-45. PubMed ID: 9288609 [TBL] [Abstract][Full Text] [Related]
17. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths. Terada T; Nakanuma Y Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):327-35. PubMed ID: 1348889 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B antigen in the liver cells in cirrhosis and hepatocellular carcinoma. Tan AY; Law CH; Lee YS Pathology; 1977 Jan; 9(1):57-64. PubMed ID: 67588 [TBL] [Abstract][Full Text] [Related]
19. Altered zonal expression of the CD26 antigen (dipeptidyl peptidase IV) in human cirrhotic liver. Matsumoto Y; Bishop GA; McCaughan GW Hepatology; 1992 Jun; 15(6):1048-53. PubMed ID: 1350563 [TBL] [Abstract][Full Text] [Related]
20. CD10 immunostaining of bile canaliculi in liver biopsies: change of staining pattern with the development of cirrhosis. Shousha S; Gadir F; Peston D; Bansi D; Thillainaygam AV; Murray-Lyon IM Histopathology; 2004 Oct; 45(4):335-42. PubMed ID: 15469471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]